Chronic active Epstein-Bar virus infection complicated by pulmonary artery hypertension

Okano, 2005, Proposed guidelines for diagnosing chronic active epstein-barr virus infection, Am J Hematol, 80, 64, 10.1002/ajh.20398 Sawada, 2017, How we treat chronic active epstein-barr virus infection, Int J Hematol, 105, 406, 10.1007/s12185-017-2192-6 Kimura, 2012, Ebv-associated t/nk-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases, Blood, 119, 673, 10.1182/blood-2011-10-381921 Fox, 2010, Epstein-barr virus-associated hemophagocytic lymphohistiocytosis in adults characterized by high viral genome load within circulating natural killer cells, Clin Infect Dis, 51, 66, 10.1086/653424 Henter, 2007, Hlh-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis, Pediatr Blood Cancer, 48, 124, 10.1002/pbc.21039 Luo, 2018, The clinical characteristics and the features of immunophenotype of peripheral lymphocytes of adult onset chronic active epstein-barr virus disease at a tertiary care hospital in beijing, Medicine (Baltim), 97 Yonese, 2020, Nationwide survey of systemic chronic active ebv infection in Japan in accordance with the new who classification, Blood Adv, 4, 2918, 10.1182/bloodadvances.2020001451 Fujiwara, 2014, Current research on chronic active epstein-barr virus infection in Japan, Pediatr Int, 56, 159, 10.1111/ped.12314 Ba, 2019, Chronic active epstein-barr virus infection with systemic vasculitis and pulmonary arterial hypertension in a child, Front Pediatr, 7, 219, 10.3389/fped.2019.00219 Muneuchi, 2009, Cardiovascular complications associated with chronic active epstein-barr virus infection, Pediatr Cardiol, 30, 274, 10.1007/s00246-008-9343-8 Heath, 1958, The pathology of hypertensive pulmonary vascular disease; a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects, Circulation, 18, 533, 10.1161/01.CIR.18.4.533 Arai, 2011, Clinical features of adult-onset chronic active epstein-barr virus infection: a retrospective analysis, Int J Hematol, 93, 602, 10.1007/s12185-011-0831-x Hauptmann, 2001, Fatal atypical t-cell proliferation associated with epstein-barr virus infection, Br J Haematol, 112, 377, 10.1046/j.1365-2141.2001.02550.x Akagi, 2020, Chemotherapy improved pulmonary arterial hypertension in a patient with chronic-active epstein-barr virus infection, Int Heart J, 61, 191, 10.1536/ihj.19-419 Fukuda, 2015, Pulmonary arterial hypertension associated with chronic active epstein-barr virus infection, Pediatr Int, 57, 731, 10.1111/ped.12578 Hashimoto, 2011, Pulmonary arterial hypertension associated with chronic active epstein-barr virus infection, Intern Med, 50, 119, 10.2169/internalmedicine.50.4143 Onishi, 2014, Resolution of chronic active ebv infection and coexisting pulmonary arterial hypertension after cord blood transplantation, Bone Marrow Transplant, 49, 1343, 10.1038/bmt.2014.129 Nakagawa, 1996, Chronic active epstein-barr virus infection with giant coronary aneurysms, Am J Clin Pathol, 105, 733, 10.1093/ajcp/105.6.733 Kanno, 2008, Adhesion of epstein-barr virus-positive natural killer cell lines to cultured endothelial cells stimulated with inflammatory cytokines, Clin Exp Immunol, 151, 519, 10.1111/j.1365-2249.2007.03584.x